Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|October 4, 2017
Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir RegimenStefan Bourgeois, Yves Horsmans, Frederik Nevens, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2017
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosisTarik Asselah, Stefan Bourgeois, Stephen Pianko, et al.
Journal of Viral Hepatitis|January 23, 2025
Severe Liver-Related Outcomes in Patients With Hepatitis Delta: Results From a Multi-Ethnic Multicenter Long-Term Follow-Up StudyArno Furquim d'Almeida, Erwin Ho, Liesbeth Govaerts, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2017
Simeprevir and daclatasvir for 12 or 24 weeks in treatment-naïve patients with hepatitis C virus genotype 1b and advanced liver diseaseChristophe Hézode, Piero L Almasio, Stefan Bourgeois, et al.
Gastroenterology|April 29, 2020
JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic InfectionFabien Zoulim, Oliver Lenz, Joris J Vandenbossche, et al.
NPJ Vaccines|February 5, 2026
Safety, immunogenicity, and baseline immune correlates of vaccine JNJ-0535 in participants with or without CHBSimon Verheijden, Nádia Conceição-Neto, Stefan Bourgeois, et al.
Journal of Viral Hepatitis|June 20, 2019
Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infectionTarik Asselah, Stephen D Shafran, Stefan Bourgeois, et al.
Plos One|January 27, 2017
Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from BelgiumDelphine Degré, Thomas Sersté, Luc Lasser, et al.
Journal of Hepatology|October 18, 2015
Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeksJordan J Feld, Christophe Moreno, Roger Trinh, et al.
BMC Infectious Diseases|June 4, 2017
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover studyEdward J Gane, Edwin DeJesus, Ewa Janczewska, et al.
Pageof 4